During the past decade, Sanatorio Otamendi y Miroli conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio Otamendi y Miroli" #1 sponsor was "Centro de estudios en Cardiologia Intervencionista" with 2 trials, followed by "Actelion" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Hospital Universitario Getafe" with 1 trials sponsored and "National Institute of Environmental Health Sciences (NIEHS)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Otamendi y Miroli" #1 collaborator was "Clínica Bazterrica" with 1 trials as a collaborator, "Eucatech AG" with 1 trials as a collaborator, "National Agency for Scientific and Technological Promotion, Argentina" with 1 trials as a collaborator and "Sanatorio Otamendi y Miroli" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio Otamendi y Miroli" are "Acute Respiratory Failure" (1 trials), "Bronchopulmonary Dysplasia" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Heart Disease" (1 trials) and "Coronary Restenosis" (1 trials). Many other conditions were trialed in "Sanatorio Otamendi y Miroli" in a lesser frequency.

Most popular intervention types in "Sanatorio Otamendi y Miroli" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ambrisentan" (1 trials), "Bare Metal Stent" (1 trials), "Drug Eluting Stent" (1 trials), "Drug Eluting stent" (1 trials) and "Oral sirolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Otamendi y Miroli" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio Otamendi y Miroli". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sanatorio Otamendi y Miroli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Otamendi y Miroli, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".